<?xml version="1.0"?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2015//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_150101.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Owner="KIE" Status="MEDLINE">        <PMID Version="1">11644321</PMID>        <DateCreated>            <Year>1989</Year>            <Month>06</Month>            <Day>15</Day>        </DateCreated>        <DateCompleted>            <Year>1989</Year>            <Month>06</Month>            <Day>15</Day>        </DateCompleted>        <DateRevised>            <Year>2013</Year>            <Month>03</Month>            <Day>26</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4885</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Dec</Month>                        <Day>16</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Gene transfer test back on track.</ArticleTitle>            <Pagination>                <MedlinePgn>1502</MedlinePgn>            </Pagination>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Roberts</LastName>                    <ForeName>Leslie</ForeName>                    <Initials>L</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016433">News</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>E</CitationSubset>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D026683">Advisory Committees</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D015316">Genetic Therapy</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D033161">Government Regulation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D006805">Human Experimentation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D009316">National Institutes of Health (U.S.)</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D033281">Nontherapeutic Human Experimentation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004364">Pharmaceutical Preparations</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011640">Public Policy</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012107">Research Design</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012306">Risk</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D012926">Social Control, Formal</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D019452">Terminally Ill</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D014162">Transfection</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <OtherID Source="KIE">27955</OtherID>        <KeywordList Owner="KIE">            <Keyword MajorTopicYN="N">Biomedical and Behavioral Research</Keyword>            <Keyword MajorTopicYN="N">Genetics and Reproduction</Keyword>            <Keyword MajorTopicYN="N">Legal Approach</Keyword>            <Keyword MajorTopicYN="Y">National Institutes of Health</Keyword>            <Keyword MajorTopicYN="Y">Recombinant DNA Advisory Committee</Keyword>        </KeywordList>        <GeneralNote Owner="KIE">KIE BoB Subject Heading: gene therapy</GeneralNote>        <GeneralNote Owner="KIE">KIE BoB Subject Heading: human experimentation/regulation</GeneralNote>        <GeneralNote Owner="KIE">News</GeneralNote>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2001</Year>                <Month>11</Month>                <Day>2</Day>                <Hour>10</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">11644321</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">3201247</PMID>        <DateCreated>            <Year>1989</Year>            <Month>01</Month>            <Day>25</Day>        </DateCreated>        <DateCompleted>            <Year>1989</Year>            <Month>01</Month>            <Day>25</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4885</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Dec</Month>                        <Day>16</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells.</ArticleTitle>            <Pagination>                <MedlinePgn>1563-6</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Mutational inactivation of the retinoblastoma susceptibility (RB) gene has been proposed as a crucial step in the formation of retinoblastoma and other types of human cancer. This hypothesis was tested by introducing, via retroviral-mediated gene transfer, a cloned RB gene into retinoblastoma or osteosarcoma cells that had inactivated endogenous RB genes. Expression of the exogenous RB gene affected cell morphology, growth rate, soft agar colony formation, and tumorigenicity in nude mice. This demonstration of suppression of the neoplastic phenotype by a single gene provides direct evidence for an essential role of the RB gene in tumorigenesis.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Huang</LastName>                    <ForeName>H J</ForeName>                    <Initials>HJ</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, School of Medicine, University of California, San Diego, La Jolla 92093.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yee</LastName>                    <ForeName>J K</ForeName>                    <Initials>JK</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Shew</LastName>                    <ForeName>J Y</ForeName>                    <Initials>JY</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Chen</LastName>                    <ForeName>P L</ForeName>                    <Initials>PL</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Bookstein</LastName>                    <ForeName>R</ForeName>                    <Initials>R</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Friedmann</LastName>                    <ForeName>T</ForeName>                    <Initials>T</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Lee</LastName>                    <ForeName>E Y</ForeName>                    <Initials>EY</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Lee</LastName>                    <ForeName>W H</ForeName>                    <Initials>WH</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>EY-05758</GrantID>                    <Acronym>EY</Acronym>                    <Agency>NEI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>HD-20034</GrantID>                    <Acronym>HD</Acronym>                    <Agency>NICHD NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D004273">DNA, Neoplasm</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002455">Cell Division</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004273">DNA, Neoplasm</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004198">Disease Susceptibility</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005134">Eye Neoplasms</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012516">Osteosarcoma</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D010641">Phenotype</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D010750">Phosphoproteins</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D010957">Plasmids</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012175">Retinoblastoma</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D013489">Suppression, Genetic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014158">Transcription, Genetic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D014162">Transfection</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014407">Tumor Cells, Cultured</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">3201247</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">3201246</PMID>        <DateCreated>            <Year>1989</Year>            <Month>01</Month>            <Day>25</Day>        </DateCreated>        <DateCompleted>            <Year>1989</Year>            <Month>01</Month>            <Day>25</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>03</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4885</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Dec</Month>                        <Day>16</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Human T cell leukemia viruses use a receptor determined by human chromosome 17.</ArticleTitle>            <Pagination>                <MedlinePgn>1557-9</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Human T cell leukemia viruses (HTLV-I and HTLV-II) can infect many cell types in vitro. HTLV-I and HTLV-II use the same cell surface receptor, as shown by interference with syncytium formation and with infection by vesicular stomatitis virus (VSV) pseudotypes bearing the HTLV envelope glycoproteins. Human-mouse somatic cell hybrids were used to determine which human chromosome was required to confer susceptibility to VSV(HTLV) infection. The only human chromosome common to all susceptible cell hybrids was chromosome 17, and the receptor gene was localized to 17cen-qter. Antibodies to surface antigens known to be determined by genes on 17q did not block the HTLV receptor.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Sommerfelt</LastName>                    <ForeName>M A</ForeName>                    <Initials>MA</Initials>                    <AffiliationInfo>                        <Affiliation>Chester Beatty Laboratories, Institute of Cancer Research, London, U.K.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Williams</LastName>                    <ForeName>B P</ForeName>                    <Initials>BP</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Clapham</LastName>                    <ForeName>P R</ForeName>                    <Initials>PR</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Solomon</LastName>                    <ForeName>E</ForeName>                    <Initials>E</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Goodfellow</LastName>                    <ForeName>P N</ForeName>                    <Initials>PN</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Weiss</LastName>                    <ForeName>R A</ForeName>                    <Initials>RA</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CitationSubset>X</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002417">Cattle</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002460">Cell Line</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002874">Chromosome Mapping</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D002886">Chromosomes, Human, Pair 17</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006224">Cricetinae</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D005796">Genes</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015368">Human T-lymphotropic virus 1</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015367">Human T-lymphotropic virus 2</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006822">Hybrid Cells</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000166">cytology</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011991">Receptors, Virus</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">3201246</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">3201245</PMID>        <DateCreated>            <Year>1989</Year>            <Month>01</Month>            <Day>25</Day>        </DateCreated>        <DateCompleted>            <Year>1989</Year>            <Month>01</Month>            <Day>25</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4885</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Dec</Month>                        <Day>16</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection.</ArticleTitle>            <Pagination>                <MedlinePgn>1554-7</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>The expression of a laboratory strain of HIV-1 (HTLV-IIIB) has been studied in mitogen-stimulated peripheral blood lymphocytes (PBLs) and in two lymphoid cell lines (CEM cells and C8166 cells). HIV-expressing cells contained from 300,000 to 2,500,000 copies of viral RNA per cell. Near-synchronous expression of an active infection could be achieved in C8166 cells. In these cells, the high copy numbers of viral RNA used as much as 40% of total protein synthesis for the production of viral gag protein, with high levels of viral RNA and protein synthesis preceding cell death by 2 to 4 days.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Somasundaran</LastName>                    <ForeName>M</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, University of Massachusetts Medical Center, Worcester 01655.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Robinson</LastName>                    <ForeName>H L</ForeName>                    <Initials>HL</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>AI 24474</GrantID>                    <Acronym>AI</Acronym>                    <Agency>NIAID NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>N01-HB-6-7022</GrantID>                    <Acronym>HB</Acronym>                    <Agency>NHLBI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CitationSubset>X</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="ErratumIn">                <RefSource>Science 1990 Mar 30;247(4950):1531</RefSource>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002460">Cell Line</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D002472">Cell Transformation, Viral</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015497">HIV-1</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000254">growth &amp; development</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D007700">Kinetics</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008214">Lymphocytes</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000382">microbiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012367">RNA, Viral</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000096">biosynthesis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014764">Viral Proteins</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000096">biosynthesis</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">3201245</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">3201240</PMID>        <DateCreated>            <Year>1989</Year>            <Month>01</Month>            <Day>25</Day>        </DateCreated>        <DateCompleted>            <Year>1989</Year>            <Month>01</Month>            <Day>25</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>03</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4885</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Dec</Month>                        <Day>16</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>The global impact of the Chernobyl reactor accident.</ArticleTitle>            <Pagination>                <MedlinePgn>1513-9</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Radioactive material was deposited throughout the Northern Hemisphere as a result of the accident at the Chernobyl Nuclear Power Station on 26 April 1986. On the basis of a large amount of environmental data and new integrated dose assessment and risk models, the collective dose commitment to the approximately 3 billion inhabitants is calculated to be 930,000 person-gray, with 97% in the western Soviet Union and Europe. The best estimates for the lifetime expectation of fatal radiogenic cancer would increase the risk from 0 to 0.02% in Europe and 0 to 0.003% in the Northern Hemisphere. By means of an integration of the environmental data, it is estimated that approximately 100 petabecquerels of cesium-137 (1 PBq = 10(15) Bq) were released during and subsequent to the accident.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Anspaugh</LastName>                    <ForeName>L R</ForeName>                    <Initials>LR</Initials>                    <AffiliationInfo>                        <Affiliation>Lawrence Livermore National Laboratory, Livermore, CA 94550.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Catlin</LastName>                    <ForeName>R J</ForeName>                    <Initials>RJ</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Goldman</LastName>                    <ForeName>M</ForeName>                    <Initials>M</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011847">Radioactive Fallout</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D000059">Accidents</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009381">Neoplasms, Radiation-Induced</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D009688">Nuclear Reactors</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011830">Radiation Effects</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D011847">Radioactive Fallout</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014455">Ukraine</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">3201240</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">3144043</PMID>        <DateCreated>            <Year>1989</Year>            <Month>01</Month>            <Day>25</Day>        </DateCreated>        <DateCompleted>            <Year>1989</Year>            <Month>01</Month>            <Day>25</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>03</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4885</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Dec</Month>                        <Day>16</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>A DNA binding protein regulated by IL-4 and by differentiation in B cells.</ArticleTitle>            <Pagination>                <MedlinePgn>1559-62</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>The class II (Ia) major histocompatibility complex antigens are a family of integral membrane proteins whose expression is limited to certain cell types, predominantly B lymphocytes, macrophages, and thymic epithelial cells. In B cells, Ia expression is both developmentally regulated and responsive to external stimuli. The differentiation of early B stem cells to mature B lymphocytes is accompanied by the appearance of cell surface Ia antigens; the transition to plasma cells results in loss of class II gene expression. In Ia-expressing B cells, the T cell-derived lymphokine interleukin-4 (IL-4) increases such expression by an as yet undefined mechanism. Chloramphenicol acetyltransferase gene expression was cis-activated by a region of the Ia A alpha k gene in a B lymphoma line, but not in a myeloma line. A nuclear protein that bound to two sites within this region, upstream from previously described transcription elements, was found in normal spleen cells. This binding activity was also found in spleen extracts from athymic mice, which lack T lymphocytes, and in Ia-positive B lymphocyte tumor cell lines, demonstrating that it is a B cell protein. Further analysis showed the activity to be undetectable in an Ia-negative pre-B cell line and in three plasmacytoma cell lines that are Ia negative. IL-4 treatment of normal and athymic mouse spleen cells greatly increased the binding of this nuclear protein to these two sites, concomitant with increased MHC class II gene transcription. Thus, B cells contain a sequence-specific DNA-binding activity whose level is influenced both by IL-4 and by differentiation signals.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Boothby</LastName>                    <ForeName>M</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Cancer Biology, Harvard School of Public Health, Boston, MA 02115.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gravallese</LastName>                    <ForeName>E</ForeName>                    <Initials>E</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Liou</LastName>                    <ForeName>H C</ForeName>                    <Initials>HC</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Glimcher</LastName>                    <ForeName>L H</ForeName>                    <Initials>LH</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D007378">Interleukins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>207137-56-2</RegistryNumber>                <NameOfSubstance UI="D015847">Interleukin-4</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D001402">B-Lymphocytes</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000166">cytology</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>                <QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D001483">Base Sequence</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002454">Cell Differentiation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002460">Cell Line</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004268">DNA-Binding Proteins</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005802">Genes, MHC Class II</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015847">Interleukin-4</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D007378">Interleukins</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>12</Month>                <Day>16</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">3144043</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">2904699</PMID>        <DateCreated>            <Year>1989</Year>            <Month>01</Month>            <Day>19</Day>        </DateCreated>        <DateCompleted>            <Year>1989</Year>            <Month>01</Month>            <Day>19</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4884</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Dec</Month>                        <Day>9</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Metabolic correction of defects in the lipid anchoring of Thy-1 in lymphoma mutants.</ArticleTitle>            <Pagination>                <MedlinePgn>1446-8</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Many plasma membrane proteins, including Thy-1, are anchored by a carboxyl terminal glycophospholipid. This unit is absent from the Thy-1 of several lymphoma mutants that synthesize the Thy-1 polypeptide but fail to express it at the cell surface. Recessive mutants of complementation groups A to C, E, and F contain Thy-1 mRNA of normal size, which suggests that their Thy-1 polypeptide is normal. To identify possible metabolic lesions, each mutant was grown with various supplements. The class F and B mutants exhibited a reversible induction of surface lipid anchored Thy-1 when grown with the aminoglycoside G418. Other aminoglycosides, sugars, and ethanolamine were inactive. These unexpected observations are discussed in the context of lipid anchor biosynthesis.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Gupta</LastName>                    <ForeName>D</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Case Western Reserve University, Cleveland, OH 44106.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tartakoff</LastName>                    <ForeName>A</ForeName>                    <Initials>A</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Tisdale</LastName>                    <ForeName>E</ForeName>                    <Initials>E</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="N">                <Grant>                    <GrantID>AI21269</GrantID>                    <Acronym>AI</Acronym>                    <Agency>NIAID NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>DK27651</GrantID>                    <Acronym>DK</Acronym>                    <Agency>NIDDK NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>DK38181</GrantID>                    <Acronym>DK</Acronym>                    <Agency>NIDDK NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000954">Antigens, Surface</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D018800">Antigens, Thy-1</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D005839">Gentamicins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D008563">Membrane Lipids</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D010743">Phospholipids</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>49863-47-0</RegistryNumber>                <NameOfSubstance UI="C010680">antibiotic G 418</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000900">Anti-Bacterial Agents</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000954">Antigens, Surface</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D018800">Antigens, Thy-1</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002460">Cell Line</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002462">Cell Membrane</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005839">Gentamicins</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006031">Glycosylation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008223">Lymphoma</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008563">Membrane Lipids</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D009154">Mutation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D010743">Phospholipids</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011499">Protein Processing, Post-Translational</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012333">RNA, Messenger</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000302">isolation &amp; purification</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>12</Month>                <Day>9</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>12</Month>                <Day>9</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>12</Month>                <Day>9</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">2904699</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">2849206</PMID>        <DateCreated>            <Year>1989</Year>            <Month>01</Month>            <Day>19</Day>        </DateCreated>        <DateCompleted>            <Year>1989</Year>            <Month>01</Month>            <Day>19</Day>        </DateCompleted>        <DateRevised>            <Year>2013</Year>            <Month>11</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4884</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Dec</Month>                        <Day>9</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein.</ArticleTitle>            <Pagination>                <MedlinePgn>1412-5</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Erythropoietin (Epo), the hormone that stimulates red blood cell production, is synthesized in the kidney and liver in response to hypoxia. The human hepatoma cell line Hep3B regulates its production of Epo in a physiologic manner. Either hypoxia or cobalt chloride markedly increases expression of Epo mRNA as well as production of biologically active and immunologically distinct Epo protein. New protein synthesis is required before the induction of increased levels of hypoxia- or cobalt-induced Epo mRNA. Hypoxia, cobalt chloride, and nickel chloride appear to stimulate Epo production through a common pathway. The inhibition of Epo production at low partial pressures of oxygen by carbon monoxide provides evidence that a heme protein is integrally involved in the oxygen-sensing mechanism. This hypothesis is further supported by the finding that when heme synthesis is blocked, hypoxia-, cobalt-, and nickel-induced Epo production are all markedly inhibited. A model is proposed in which a ligand-dependent conformational change in a heme protein accounts for the mechanism by which hypoxia as well as cobalt and nickel stimulate the production of Epo.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Goldberg</LastName>                    <ForeName>M A</ForeName>                    <Initials>MA</Initials>                    <AffiliationInfo>                        <Affiliation>Howard Hughes Medical Institute, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dunning</LastName>                    <ForeName>S P</ForeName>                    <Initials>SP</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Bunn</LastName>                    <ForeName>H F</ForeName>                    <Initials>HF</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>DK01401</GrantID>                    <Acronym>DK</Acronym>                    <Agency>NIDDK NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D006420">Hemeproteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>11096-26-7</RegistryNumber>                <NameOfSubstance UI="D004921">Erythropoietin</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>3G0H8C9362</RegistryNumber>                <NameOfSubstance UI="D003035">Cobalt</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>42Z2K6ZL8P</RegistryNumber>                <NameOfSubstance UI="D008345">Manganese</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>7OV03QG267</RegistryNumber>                <NameOfSubstance UI="D009532">Nickel</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>7U1EE4V452</RegistryNumber>                <NameOfSubstance UI="D002248">Carbon Monoxide</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>98600C0908</RegistryNumber>                <NameOfSubstance UI="D003513">Cycloheximide</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>E1UOL152H7</RegistryNumber>                <NameOfSubstance UI="D007501">Iron</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000693">Anaerobiosis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002248">Carbon Monoxide</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006528">Carcinoma, Hepatocellular</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002460">Cell Line</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D003035">Cobalt</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D003513">Cycloheximide</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004921">Erythropoietin</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D005786">Gene Expression Regulation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D005796">Genes</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006420">Hemeproteins</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D007501">Iron</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008113">Liver Neoplasms</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008345">Manganese</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009532">Nickel</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D014158">Transcription, Genetic</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>12</Month>                <Day>9</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>12</Month>                <Day>9</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>12</Month>                <Day>9</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">2849206</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">3057627</PMID>        <DateCreated>            <Year>1989</Year>            <Month>01</Month>            <Day>04</Day>        </DateCreated>        <DateCompleted>            <Year>1989</Year>            <Month>01</Month>            <Day>04</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>03</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4883</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Dec</Month>                        <Day>2</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Scientific standards in epidemiologic studies of the menace of daily life.</ArticleTitle>            <Pagination>                <MedlinePgn>1257-63</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Many substances used in daily life, such as coffee, alcohol, and pharmaceutical treatment for hypertension, have been accused of &quot;menace&quot; in causing cancer or other major diseases. Although some of the accusations have subsequently been refuted or withdrawn, they have usually been based on statistical associations in epidemiologic studies that could not be done with the customary experimental methods of science. With these epidemiologic methods, however, the fundamental scientific standards used to specify hypotheses and groups, get high-quality data, analyze attributable actions, and avoid detection bias may also be omitted. Despite peer-review approval, the current methods need substantial improvement to produce trustworthy scientific evidence.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Feinstein</LastName>                    <ForeName>A R</ForeName>                    <Initials>AR</Initials>                    <AffiliationInfo>                        <Affiliation>Clinical Epidemiology Unit, Yale University School of Medicine, New Haven, CT 06510.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="CommentIn">                <RefSource>Science. 1989 Mar 10;243(4896):1255-6</RefSource>                <PMID Version="1">2922609</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004813">Epidemiology</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000592">standards</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012107">Research Design</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <NumberOfReferences>49</NumberOfReferences>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>12</Month>                <Day>2</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>12</Month>                <Day>2</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>12</Month>                <Day>2</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">3057627</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">2973125</PMID>        <DateCreated>            <Year>1988</Year>            <Month>12</Month>            <Day>22</Day>        </DateCreated>        <DateCompleted>            <Year>1988</Year>            <Month>12</Month>            <Day>22</Day>        </DateCompleted>        <DateRevised>            <Year>2010</Year>            <Month>11</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4882</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Nov</Month>                        <Day>25</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Microinjected DNA from the X chromosome affects sex determination in Caenorhabditis elegans.</ArticleTitle>            <Pagination>                <MedlinePgn>1146-51</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>The signal for sex determination in the nematode Caenorhabditis elegans is the ratio of the number of X chromosomes to the number of sets of autosomes (X/A ratio). By previous genetic tests, elements that feminized chromosomal males appeared to be widespread on the X chromosome, but the nature of these elements was not determined. In experiments to define a feminizing element molecularly, cloned sequences were added to chromosomally male embryos by microinjection into the mother. Three different X-chromosome clones, including part of an actin gene, part of a myosin heavy chain gene, and all of two myosin light chain genes, feminize chromosomal males. Both somatic and germline aspects of sex determination are affected. In contrast, about 40 kilobases of nematode autosomal DNA, phage lambda DNA, and plasmid pBR322 DNA do not affect sex determination. A feminizing region was localized to a maximum of 131 base pairs within an intron of the X-linked actin gene; a part of the gene that does not have this region is not feminizing. The results suggest that short, discrete elements found associated with many X-linked genes may act as signals for sex determination in C. elegans.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>McCoubrey</LastName>                    <ForeName>W K</ForeName>                    <Initials>WK</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nordstrom</LastName>                    <ForeName>K D</ForeName>                    <Initials>KD</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Meneely</LastName>                    <ForeName>P M</ForeName>                    <Initials>PM</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <DataBankList CompleteYN="Y">                <DataBank>                    <DataBankName>GENBANK</DataBankName>                    <AccessionNumberList>                        <AccessionNumber>M23262</AccessionNumber>                    </AccessionNumberList>                </DataBank>            </DataBankList>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>5T32CA09437-06</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D003160">Comparative Study</PublicationType>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000199">Actins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D004274">DNA, Recombinant</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.6.4.1</RegistryNumber>                <NameOfSubstance UI="D009218">Myosins</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000199">Actins</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D010582">Bacteriophage lambda</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D001483">Base Sequence</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002107">Caenorhabditis</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004274">DNA, Recombinant</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004279">DNA, Viral</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012734">Disorders of Sex Development</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005091">Exons</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D007438">Introns</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008845">Microinjections</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009218">Myosins</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D010641">Phenotype</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D010957">Plasmids</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D012732">Sex Determination Analysis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014170">Transformation, Genetic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D014960">X Chromosome</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>11</Month>                <Day>25</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>11</Month>                <Day>25</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>11</Month>                <Day>25</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">2973125</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">2847317</PMID>        <DateCreated>            <Year>1988</Year>            <Month>12</Month>            <Day>22</Day>        </DateCreated>        <DateCompleted>            <Year>1988</Year>            <Month>12</Month>            <Day>22</Day>        </DateCompleted>        <DateRevised>            <Year>2013</Year>            <Month>11</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4882</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Nov</Month>                        <Day>25</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Inositol 1,3,4,5-tetrakisphosphate induces Ca2+ sequestration in rat liver cells.</ArticleTitle>            <Pagination>                <MedlinePgn>1176-8</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Inositol 1,4,5-trisphosphate [I(1,4,5)P3] is a second messenger generated along with diacylglycerol upon the binding of various physiological agents with their cell surface receptors. I(1,4,5)P3 mobilizes Ca2+ from intracellular storage sites through a receptor-coupled mechanism, and the subsequent increased intracellular free calcium ion concentration [( Ca2+]i) activates a multitude of cellular responses. Electropermeabilized neoplastic rat liver epithelial (261B) cells were used to study Ca2+ sequestration, a process that reverses the elevated [Ca2+]i to resting levels and replenishes intracellular Ca2+ pools. Although I (1,4,5)P3-mobilized Ca2+ is readily sequestered into storage pools by the action of Ca2+-adenosine triphosphatases, Ca2+ mobilized by addition of the nonmetabolized inositol trisphosphate isomer I(2,4,5)P3 is not sequestered, suggesting that metabolism is necessary to eliminate the stimulus for Ca2+ release. Several inositol phosphate compounds were examined for their ability to lower the buffer [Ca2+] to determine if a specific I(1,4,5)P3 metabolite might be involved in stimulating Ca2+ sequestration; of these, I(1,3,4,5)P4 alone was found to induce Ca2+ sequestration, demonstrating a physiological role for this inositol trisphosphate metabolite.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Hill</LastName>                    <ForeName>T D</ForeName>                    <Initials>TD</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Research Center of Hawaii, University of Hawaii, Honolulu 96813.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dean</LastName>                    <ForeName>N M</ForeName>                    <Initials>NM</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Boynton</LastName>                    <ForeName>A L</ForeName>                    <Initials>AL</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>CA 39745</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>CA 42942</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D015220">Calcium Channels</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D053496">Inositol 1,4,5-Trisphosphate Receptors</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D007295">Inositol Phosphates</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011956">Receptors, Cell Surface</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D013403">Sugar Phosphates</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>102850-29-3</RegistryNumber>                <NameOfSubstance UI="C081655">inositol-1,3,4,5-tetrakisphosphate</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>85166-31-0</RegistryNumber>                <NameOfSubstance UI="D015544">Inositol 1,4,5-Trisphosphate</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.6.3.8</RegistryNumber>                <NameOfSubstance UI="D000252">Calcium-Transporting ATPases</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>SY7Q814VUP</RegistryNumber>                <NameOfSubstance UI="D002118">Calcium</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002118">Calcium</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D015220">Calcium Channels</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000252">Calcium-Transporting ATPases</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002463">Cell Membrane Permeability</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004848">Epithelium</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015544">Inositol 1,4,5-Trisphosphate</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D053496">Inositol 1,4,5-Trisphosphate Receptors</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D007295">Inositol Phosphates</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>                <QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008099">Liver</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>                <QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008114">Liver Neoplasms, Experimental</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011956">Receptors, Cell Surface</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D018160">Receptors, Cytoplasmic and Nuclear</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013403">Sugar Phosphates</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014407">Tumor Cells, Cultured</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>11</Month>                <Day>25</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>11</Month>                <Day>25</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>11</Month>                <Day>25</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">2847317</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">2461587</PMID>        <DateCreated>            <Year>1989</Year>            <Month>01</Month>            <Day>04</Day>        </DateCreated>        <DateCompleted>            <Year>1989</Year>            <Month>01</Month>            <Day>04</Day>        </DateCompleted>        <DateRevised>            <Year>2008</Year>            <Month>11</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4881</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Nov</Month>                        <Day>18</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Activation of developmentally mutated human globin genes by cell fusion.</ArticleTitle>            <Pagination>                <MedlinePgn>1056-8</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Human fetal globin genes are not expressed in hybrid cells produced by the fusion of normal human lymphocytes with mouse erythroleukemia cells. In contrast, when lymphocytes from persons with globin gene developmental mutations (hereditary persistence of fetal hemoglobin) are used for these fusions, fetal globin is expressed in the hybrid cells. Thus, mutations of developmental origin can be reconstituted in vitro by fusing mutant lymphoid cells with differentiated cell lines of the proper lineage. This system can readily be used for analyses, such as globin gene methylation, that normally require large numbers of pure nucleated erythroid cells, which are difficult to obtain.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Papayannopoulou</LastName>                    <ForeName>T</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Hematology, University of Washington, Seattle 98195.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Enver</LastName>                    <ForeName>T</ForeName>                    <Initials>T</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Takegawa</LastName>                    <ForeName>S</ForeName>                    <Initials>S</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Anagnou</LastName>                    <ForeName>N P</ForeName>                    <Initials>NP</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Stamatoyannopoulos</LastName>                    <ForeName>G</ForeName>                    <Initials>G</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>DK30852</GrantID>                    <Acronym>DK</Acronym>                    <Agency>NIDDK NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>9004-22-2</RegistryNumber>                <NameOfSubstance UI="D005914">Globins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>9034-63-3</RegistryNumber>                <NameOfSubstance UI="D005319">Fetal Hemoglobin</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002459">Cell Fusion</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002872">Chromosome Deletion</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005319">Fetal Hemoglobin</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005786">Gene Expression Regulation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005914">Globins</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006453">Hemoglobinopathies</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004915">Leukemia, Erythroblastic, Acute</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009154">Mutation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011401">Promoter Regions, Genetic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012333">RNA, Messenger</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>11</Month>                <Day>18</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>11</Month>                <Day>18</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>11</Month>                <Day>18</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">2461587</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">3187524</PMID>        <DateCreated>            <Year>1988</Year>            <Month>12</Month>            <Day>14</Day>        </DateCreated>        <DateCompleted>            <Year>1988</Year>            <Month>12</Month>            <Day>14</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>03</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4880</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Nov</Month>                        <Day>11</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>NIH delays gene transfer experiment.</ArticleTitle>            <Pagination>                <MedlinePgn>856-7</MedlinePgn>            </Pagination>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Culliton</LastName>                    <ForeName>B J</ForeName>                    <Initials>BJ</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016433">News</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>E</CitationSubset>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D026683">Advisory Committees</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D035082">Federal Government</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005819">Genetic Markers</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D033161">Government Regulation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008214">Lymphocytes</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D009316">National Institutes of Health (U.S.)</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011643">Publishing</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D035842">Research Subjects</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D014162">Transfection</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <OtherID Source="KIE">27059</OtherID>        <KeywordList Owner="KIE">            <Keyword MajorTopicYN="N">Biomedical and Behavioral Research</Keyword>            <Keyword MajorTopicYN="N">Genetics and Reproduction</Keyword>            <Keyword MajorTopicYN="N">Legal Approach</Keyword>            <Keyword MajorTopicYN="Y">National Institutes of Health</Keyword>            <Keyword MajorTopicYN="Y">Recombinant DNA Advisory Committee</Keyword>        </KeywordList>        <GeneralNote Owner="KIE">KIE BoB Subject Heading: gene therapy</GeneralNote>        <GeneralNote Owner="KIE">KIE BoB Subject Heading: human experimentation/regulation</GeneralNote>        <GeneralNote Owner="KIE">News</GeneralNote>        <GeneralNote Owner="KIE">Full author name: Culliton, Barbara J</GeneralNote>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>11</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>11</Month>                <Day>11</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>11</Month>                <Day>11</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">3187524</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">3055296</PMID>        <DateCreated>            <Year>1988</Year>            <Month>12</Month>            <Day>08</Day>        </DateCreated>        <DateCompleted>            <Year>1988</Year>            <Month>12</Month>            <Day>08</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>03</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4879</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Nov</Month>                        <Day>4</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Anticodon switching changes the identity of methionine and valine transfer RNAs.</ArticleTitle>            <Pagination>                <MedlinePgn>765-8</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>The anticodon has previously been shown to play a role in recognition of certain transfer RNAs by aminoacyl-tRNA synthetases; however, the extent to which this sequence dictates tRNA identity is generally unknown. To investigate the contribution of the anticodon to the identity of Escherichia coli methionine and valine tRNAs, in vitro transcripts of these tRNAs were prepared that contained normal and interchanged anticodon sequences. Transcripts containing wild-type tRNA sequences were excellent substrates for their respective cognate aminoacyl-tRNA synthetases and were effectively discriminated against by a variety of noncognate enzymes. The mutant tRNAs produced by switching the anticodon sequences lost their original tRNA identity and assumed an identity corresponding to the acquired anticodon sequence. These results indicate that the anticodon contains sufficient information to distinguish methionine and valine tRNAs with high fidelity.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Schulman</LastName>                    <ForeName>L H</ForeName>                    <Initials>LH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Developmental Biology and Cancer, Albert Einstein College of Medicine, Bronx, New York 10461.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pelka</LastName>                    <ForeName>H</ForeName>                    <Initials>H</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000926">Anticodon</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D012345">RNA, Transfer, Amino Acid-Specific</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D012358">RNA, Transfer, Met</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D012366">RNA, Transfer, Val</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>9014-25-9</RegistryNumber>                <NameOfSubstance UI="D012343">RNA, Transfer</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 6.1.1.10</RegistryNumber>                <NameOfSubstance UI="D008718">Methionine-tRNA Ligase</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 6.1.1.9</RegistryNumber>                <NameOfSubstance UI="D014637">Valine-tRNA Ligase</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D000926">Anticodon</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004926">Escherichia coli</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D007700">Kinetics</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008718">Methionine-tRNA Ligase</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D012343">RNA, Transfer</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012345">RNA, Transfer, Amino Acid-Specific</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012358">RNA, Transfer, Met</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012366">RNA, Transfer, Val</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013379">Substrate Specificity</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D046249">Transfer RNA Aminoacylation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014637">Valine-tRNA Ligase</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>11</Month>                <Day>4</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>11</Month>                <Day>4</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>11</Month>                <Day>4</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">3055296</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">3175673</PMID>        <DateCreated>            <Year>1988</Year>            <Month>11</Month>            <Day>23</Day>        </DateCreated>        <DateCompleted>            <Year>1988</Year>            <Month>11</Month>            <Day>23</Day>        </DateCompleted>        <DateRevised>            <Year>2013</Year>            <Month>11</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4878</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Oct</Month>                        <Day>28</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA.</ArticleTitle>            <Pagination>                <MedlinePgn>564-7</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>The disease xeroderma pigmentosum is characterized by deficient repair of damaged DNA. Fusions of cells from different patients have defined nine genetic complementation groups (A through I), implying that DNA repair in humans involves multiple gene products. In this report, an extension of the gel electrophoresis binding assay was used to identify at least one nuclear factor that (i) bound to DNA damaged by ultraviolet radiation or the antitumor drug cisplatin, but (ii) was notably absent in cells from complementation group E. Therefore, the factor appears to participate in a versatile DNA repair pathway at the stage of binding and recognition.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Chu</LastName>                    <ForeName>G</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Medicine, Stanford University School of Medicine, CA 94305.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chang</LastName>                    <ForeName>E</ForeName>                    <Initials>E</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>CA44949</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D015342">DNA Probes</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>Q20Q21Q62J</RegistryNumber>                <NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002460">Cell Line</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002945">Cisplatin</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D004249">DNA Damage</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015342">DNA Probes</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D004260">DNA Repair</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004268">DNA-Binding Proteins</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005816">Genetic Complementation Test</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006367">HeLa Cells</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009687">Nuclear Proteins</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014466">Ultraviolet Rays</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014983">Xeroderma Pigmentosum</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>10</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>10</Month>                <Day>28</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>10</Month>                <Day>28</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">3175673</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">2902689</PMID>        <DateCreated>            <Year>1988</Year>            <Month>11</Month>            <Day>23</Day>        </DateCreated>        <DateCompleted>            <Year>1988</Year>            <Month>11</Month>            <Day>23</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>03</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4878</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Oct</Month>                        <Day>28</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>In vivo administration of anti-CD3 prevents malignant progressor tumor growth.</ArticleTitle>            <Pagination>                <MedlinePgn>569-71</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Malignant progressor tumors are only weakly immunogenic and can evade host recognition and rejection. One approach to therapy involves activation of the host antitumor cellular effector mechanisms. Since monoclonal antibodies to CD3 (anti-CD3) can activate T cells in vitro, an attempt was made to determine if tumor immunity could be achieved by the administration of anti-CD3 in vivo. T lymphocytes from mice injected with anti-CD3 showed increased interleukin-2 receptor (IL-2R) expression, increased proliferation to recombinant IL-2 (rIL-2), and enhanced reactivity in both an allogeneic mixed lymphocyte reaction and a mixed lymphocyte tumor culture. Malignant tumor growth in treated mice was also examined. The anti-CD3 treatment prevented tumor outgrowth that would have killed untreated animals and also stimulated an in vivo response against a malignant progressor tumor providing lasting tumor immunity.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Ellenhorn</LastName>                    <ForeName>J D</ForeName>                    <Initials>JD</Initials>                    <AffiliationInfo>                        <Affiliation>University of Chicago, IL 60637.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hirsch</LastName>                    <ForeName>R</ForeName>                    <Initials>R</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Schreiber</LastName>                    <ForeName>H</ForeName>                    <Initials>H</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Bluestone</LastName>                    <ForeName>J A</ForeName>                    <Initials>JA</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D017252">Antigens, CD3</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000945">Antigens, Differentiation, T-Lymphocyte</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000954">Antigens, Surface</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D018800">Antigens, Thy-1</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011948">Receptors, Antigen, T-Cell</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D015375">Receptors, Interleukin-2</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D017252">Antigens, CD3</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000945">Antigens, Differentiation, T-Lymphocyte</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000954">Antigens, Surface</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D018800">Antigens, Thy-1</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004306">Dose-Response Relationship, Immunologic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D007165">Immunosuppression</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D007167">Immunotherapy</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008198">Lymph Nodes</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D008213">Lymphocyte Activation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009368">Neoplasm Transplantation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009374">Neoplasms, Experimental</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011948">Receptors, Antigen, T-Cell</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015375">Receptors, Interleukin-2</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013601">T-Lymphocytes</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>10</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>10</Month>                <Day>28</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>10</Month>                <Day>28</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">2902689</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">2845582</PMID>        <DateCreated>            <Year>1988</Year>            <Month>11</Month>            <Day>23</Day>        </DateCreated>        <DateCompleted>            <Year>1988</Year>            <Month>11</Month>            <Day>23</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>11</Month>            <Day>15</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4878</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Oct</Month>                        <Day>28</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>T cell CD3-zeta eta heterodimer expression and coupling to phosphoinositide hydrolysis.</ArticleTitle>            <Pagination>                <MedlinePgn>571-4</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>The T cell antigen receptor consists of an antigen-binding heterodimer that is noncovalently associated with at least five CD3 subunits (gamma, delta, epsilon, zeta, and eta). The CD3-zeta chains are either disulfide-linked homodimers (CD3-zeta 2) or disulfide-linked heterodimers with eta (CD3-zeta eta). Variants of a murine antigen-specific T cell hybridoma that express normal amounts of CD3-zeta 2 but decreased amounts of CD3-zeta eta were isolated. When activated, the parental cell line increased both phosphatidylinositol hydrolysis and serine-specific protein kinase activity to a much greater extent than the variants. In contrast, the activation of a tyrosine-specific kinase after stimulation with a cross-linking antibody to CD3 was similar among these cells. There was a positive linear relation between the expression of CD3-zeta eta and phosphoinositide hydrolysis stimulated by the TCR, suggesting a differential coupling of the T cell alpha beta heterodimer to signal transduction mechanisms due to alpha beta association with either CD3-zeta 2 or CD3-zeta eta.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Merćep</LastName>                    <ForeName>M</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Biological Response Modifiers Program, National Cancer Institute, Bethesda, MD 20892.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bonifacino</LastName>                    <ForeName>J S</ForeName>                    <Initials>JS</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Garcia-Morales</LastName>                    <ForeName>P</ForeName>                    <Initials>P</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Samelson</LastName>                    <ForeName>L E</ForeName>                    <Initials>LE</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Klausner</LastName>                    <ForeName>R D</ForeName>                    <Initials>RD</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Ashwell</LastName>                    <ForeName>J D</ForeName>                    <Initials>JD</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000941">Antigens</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D017252">Antigens, CD3</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000945">Antigens, Differentiation, T-Lymphocyte</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D046911">Macromolecular Substances</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D010716">Phosphatidylinositols</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011948">Receptors, Antigen, T-Cell</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C054979">antigen T cell receptor, zeta chain</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.11.13</RegistryNumber>                <NameOfSubstance UI="D011493">Protein Kinase C</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000941">Antigens</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D017252">Antigens, CD3</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000945">Antigens, Differentiation, T-Lymphocyte</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002460">Cell Line</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015180">Electrophoresis, Gel, Two-Dimensional</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D046911">Macromolecular Substances</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D008565">Membrane Proteins</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D010716">Phosphatidylinositols</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D010750">Phosphoproteins</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D010766">Phosphorylation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011233">Precipitin Tests</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011493">Protein Kinase C</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011948">Receptors, Antigen, T-Cell</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013601">T-Lymphocytes</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>10</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>10</Month>                <Day>28</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>10</Month>                <Day>28</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">2845582</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">3262925</PMID>        <DateCreated>            <Year>1988</Year>            <Month>11</Month>            <Day>17</Day>        </DateCreated>        <DateCompleted>            <Year>1988</Year>            <Month>11</Month>            <Day>17</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>03</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4877</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Oct</Month>                        <Day>21</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.</ArticleTitle>            <Pagination>                <MedlinePgn>426-30</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Studies of the biology and pathogenesis of Kaposi's sarcoma (KS) have been hampered by the inability to maintain long-term cultures of KS cells in vitro. In this study AIDS-KS-derived cells with characteristic spindle-like morphology were cultured with a growth factor (or factors) released by CD4+ T lymphocytes infected with human T-lymphotropic virus type I or II (HTLV-I or HTLV-II) or with human immunodeficiency virus type 1 or 2 (HIV-1 or HIV-2). Medium conditioned by HTLV-II-infected, transformed lines of T cells (HTLV-II CM) contained large amounts of this growth activity and also supported the temporary growth of normal vascular endothelial cells, but not fibroblasts. Interleukin-1 and tumor necrosis factor-alpha stimulated the growth of the KS-derived cells, but the growth was only transient and these could be distinguished from that in HTLV-II CM. Other known endothelial cell growth promoting factors, such as acidic and basic fibroblast growth factors and epidermal growth factor, did not support the long-term growth of the AIDS-KS cells. The factor released by CD4+ T cells infected with human retroviruses should prove useful in studies of the pathogenesis of KS.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Nakamura</LastName>                    <ForeName>S</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Laboratory of Tumor Cell Biology, National Cancer Institute, Bethesda, MD 20892.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Salahuddin</LastName>                    <ForeName>S Z</ForeName>                    <Initials>SZ</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Biberfeld</LastName>                    <ForeName>P</ForeName>                    <Initials>P</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Ensoli</LastName>                    <ForeName>B</ForeName>                    <Initials>B</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Markham</LastName>                    <ForeName>P D</ForeName>                    <Initials>PD</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Wong-Staal</LastName>                    <ForeName>F</ForeName>                    <Initials>F</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Gallo</LastName>                    <ForeName>R C</ForeName>                    <Initials>RC</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000945">Antigens, Differentiation, T-Lymphocyte</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D006133">Growth Substances</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CitationSubset>X</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000163">Acquired Immunodeficiency Syndrome</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>                <QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000945">Antigens, Differentiation, T-Lymphocyte</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002455">Cell Division</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D002472">Cell Transformation, Viral</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006133">Growth Substances</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000302">isolation &amp; purification</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015368">Human T-lymphotropic virus 1</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015367">Human T-lymphotropic virus 2</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D007700">Kinetics</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012514">Sarcoma, Kaposi</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013601">T-Lymphocytes</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014407">Tumor Cells, Cultured</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>10</Month>                <Day>21</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>10</Month>                <Day>21</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>10</Month>                <Day>21</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">3262925</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">3175662</PMID>        <DateCreated>            <Year>1988</Year>            <Month>11</Month>            <Day>17</Day>        </DateCreated>        <DateCompleted>            <Year>1988</Year>            <Month>11</Month>            <Day>17</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>03</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4877</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Oct</Month>                        <Day>21</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts.</ArticleTitle>            <Pagination>                <MedlinePgn>405-11</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Expression of a complementary DNA (cDNA) encoding the mouse MyoD1 protein in a variety of fibroblast and adipoblast cell lines converts them to myogenic cells. Polyclonal antisera to fusion proteins containing the MyoD1 sequence show that MyoD1 is a phosphoprotein present in the nuclei of proliferating myoblasts and differentiated myotubes but not expressed in 10T1/2 fibroblasts or other nonmuscle cell types. Functional domains of the MyoD1 protein were analyzed by site-directed deletional mutagenesis of the MyoD1 cDNA. Deletion of a highly basic region (residues 102 to 135) interferes with both nuclear localization and induction of myogenesis. Deletion of a short region (residues 143 to 162) that is similar to a conserved region in the c-Myc family of proteins eliminates the ability of the MyoD1 protein to initiate myogenesis but does not alter nuclear localization. Deletions of regions spanning the remainder of MyoD1 did not affect nuclear localization and did not inhibit myogenesis. Furthermore, expression of only 68 amino acids of MyoD1, containing the basic and the Myc similarity domains, is sufficient to activate myogenesis in stably transfected 10T1/2 cells. Genetic analysis maps the MyoD1 gene to mouse chromosome 7 and human chromosome 11.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Tapscott</LastName>                    <ForeName>S J</ForeName>                    <Initials>SJ</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Genetics, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Davis</LastName>                    <ForeName>R L</ForeName>                    <Initials>RL</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Thayer</LastName>                    <ForeName>M J</ForeName>                    <Initials>MJ</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Cheng</LastName>                    <ForeName>P F</ForeName>                    <Initials>PF</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Weintraub</LastName>                    <ForeName>H</ForeName>                    <Initials>H</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Lassar</LastName>                    <ForeName>A B</ForeName>                    <Initials>AB</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D017570">MyoD Protein</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C057363">MyoD1 myogenic differentiation protein</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>9007-49-2</RegistryNumber>                <NameOfSubstance UI="D004247">DNA</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002454">Cell Differentiation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002455">Cell Division</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002874">Chromosome Mapping</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004247">DNA</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005347">Fibroblasts</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000166">cytology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D005796">Genes</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009132">Muscles</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000166">cytology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D017570">MyoD Protein</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009687">Nuclear Proteins</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D009857">Oncogenes</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D010750">Phosphoproteins</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>10</Month>                <Day>21</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>10</Month>                <Day>21</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>10</Month>                <Day>21</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">3175662</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">3175661</PMID>        <DateCreated>            <Year>1988</Year>            <Month>11</Month>            <Day>17</Day>        </DateCreated>        <DateCompleted>            <Year>1988</Year>            <Month>11</Month>            <Day>17</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>03</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>242</Volume>                    <Issue>4877</Issue>                    <PubDate>                        <Year>1988</Year>                        <Month>Oct</Month>                        <Day>21</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>New clues about Kaposi's sarcoma.</ArticleTitle>            <Pagination>                <MedlinePgn>376-7</MedlinePgn>            </Pagination>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Barnes</LastName>                    <ForeName>D M</ForeName>                    <Initials>DM</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016433">News</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <CitationSubset>X</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000386">AIDS-Related Complex</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000163">Acquired Immunodeficiency Syndrome</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012514">Sarcoma, Kaposi</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1988</Year>                <Month>10</Month>                <Day>21</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1988</Year>                <Month>10</Month>                <Day>21</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1988</Year>                <Month>10</Month>                <Day>21</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">3175661</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>